Search
Descriptor English: Warfarin
Descriptor Spanish: Warfarina
Descriptor warfarina
Scope note: Anticoagulante que actúa inhibiendo la síntesis de factores de la coagulación dependientes de la vitamina K. La warfarina está indicada para la profilaxis y-o tratamiento de la trombosis venosa y su extensión, el embolismo pulmonar y la fibrilación auricular con embolización. También se utiliza como coadyuvante en la profilaxis del embolismo sistémico después de un infarto de miocardio. Otro uso de la warfarina es como rodenticida.
Descriptor Portuguese: Varfarina
Descriptor French: Warfarine
Entry term(s): 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
Aldocumar
Apo-Warfarin
Coumadin
Coumadine
Gen-Warfarin
Marevan
Potassium, Warfarin
Sodium, Warfarin
Tedicumar
Warfant
Warfarin Potassium
Warfarin Sodium
Tree number(s): D03.383.663.283.446.520.914
D03.633.100.150.446.520.914
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D014859
Scope note: An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.
Annotation: an anticoagulant & rodenticide
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anticoagulants
Rodenticides
Registry Number: 5Q7ZVV76EI
CAS Type 1 Name: 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-
DeCS ID: 15261
Unique ID: D014859
NLM Classification: QV 193
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/06/24
Warfarin - Preferred
Concept UI M0022871
Scope note An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.
Preferred term Warfarin
Entry term(s) 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
Apo-Warfarin - Narrower
Concept UI M0476574
Preferred term Apo-Warfarin
Aldocumar - Narrower
Concept UI M0476572
Preferred term Aldocumar
Gen-Warfarin - Narrower
Concept UI M0476571
Preferred term Gen-Warfarin
Warfant - Narrower
Concept UI M0476576
Preferred term Warfant
Coumadin - Narrower
Concept UI M0022874
Preferred term Coumadin
Entry term(s) Marevan
Warfarin Potassium - Narrower
Concept UI M0022872
Preferred term Warfarin Potassium
Entry term(s) Potassium, Warfarin
Warfarin Sodium - Narrower
Concept UI M0022873
Preferred term Warfarin Sodium
Entry term(s) Sodium, Warfarin
Coumadine - Narrower
Concept UI M0476573
Preferred term Coumadine
Tedicumar - Narrower
Concept UI M0476575
Preferred term Tedicumar



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey